nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP2C9—brain cancer	0.741	1	CbGaD
Ketobemidone—CYP3A4—Temozolomide—brain cancer	0.0532	0.291	CbGbCtD
Ketobemidone—PTGS1—Etoposide—brain cancer	0.0467	0.255	CbGbCtD
Ketobemidone—CYP3A4—Lomustine—brain cancer	0.0453	0.247	CbGbCtD
Ketobemidone—CYP2C8—Etoposide—brain cancer	0.027	0.147	CbGbCtD
Ketobemidone—CYP3A4—Etoposide—brain cancer	0.0109	0.0597	CbGbCtD
Ketobemidone—OPRM1—telencephalic ventricle—brain cancer	0.00353	0.121	CbGeAlD
Ketobemidone—OPRD1—ganglion—brain cancer	0.00322	0.111	CbGeAlD
Ketobemidone—OPRM1—ganglion—brain cancer	0.0022	0.0756	CbGeAlD
Ketobemidone—OPRD1—telencephalon—brain cancer	0.00124	0.0428	CbGeAlD
Ketobemidone—PTGS1—ganglion—brain cancer	0.00107	0.0369	CbGeAlD
Ketobemidone—UGT1A9—endocrine gland—brain cancer	0.000991	0.0341	CbGeAlD
Ketobemidone—OPRM1—brainstem—brain cancer	0.000954	0.0329	CbGeAlD
Ketobemidone—PTGS1—endothelium—brain cancer	0.000923	0.0318	CbGeAlD
Ketobemidone—PTGS1—blood vessel—brain cancer	0.000852	0.0293	CbGeAlD
Ketobemidone—OPRM1—telencephalon—brain cancer	0.000847	0.0292	CbGeAlD
Ketobemidone—OPRD1—head—brain cancer	0.000773	0.0266	CbGeAlD
Ketobemidone—OPRK1—head—brain cancer	0.000741	0.0255	CbGeAlD
Ketobemidone—OPRD1—central nervous system—brain cancer	0.000706	0.0243	CbGeAlD
Ketobemidone—OPRK1—central nervous system—brain cancer	0.000677	0.0233	CbGeAlD
Ketobemidone—OPRK1—cerebellum—brain cancer	0.000661	0.0228	CbGeAlD
Ketobemidone—OPRM1—midbrain—brain cancer	0.000608	0.0209	CbGeAlD
Ketobemidone—OPRM1—spinal cord—brain cancer	0.000593	0.0204	CbGeAlD
Ketobemidone—OPRD1—brain—brain cancer	0.00056	0.0193	CbGeAlD
Ketobemidone—OPRK1—brain—brain cancer	0.000537	0.0185	CbGeAlD
Ketobemidone—OPRM1—endocrine gland—brain cancer	0.000534	0.0184	CbGeAlD
Ketobemidone—OPRM1—head—brain cancer	0.000527	0.0182	CbGeAlD
Ketobemidone—OPRM1—central nervous system—brain cancer	0.000481	0.0166	CbGeAlD
Ketobemidone—CYP2C8—pituitary gland—brain cancer	0.000415	0.0143	CbGeAlD
Ketobemidone—PTGS1—telencephalon—brain cancer	0.000413	0.0142	CbGeAlD
Ketobemidone—OPRM1—brain—brain cancer	0.000382	0.0132	CbGeAlD
Ketobemidone—CYP2B6—gonad—brain cancer	0.000381	0.0131	CbGeAlD
Ketobemidone—CYP2C19—endocrine gland—brain cancer	0.000368	0.0127	CbGeAlD
Ketobemidone—PTGS1—pituitary gland—brain cancer	0.000336	0.0116	CbGeAlD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000324	0.00685	CbGpPWpGaD
Ketobemidone—CYP2C8—endocrine gland—brain cancer	0.000321	0.0111	CbGeAlD
Ketobemidone—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000314	0.00664	CbGpPWpGaD
Ketobemidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000311	0.00658	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.00031	0.00655	CbGpPWpGaD
Ketobemidone—PTGS1—spinal cord—brain cancer	0.000289	0.00997	CbGeAlD
Ketobemidone—CYP2B6—endocrine gland—brain cancer	0.000288	0.00992	CbGeAlD
Ketobemidone—CYP2C9—endocrine gland—brain cancer	0.000285	0.00983	CbGeAlD
Ketobemidone—CYP2B6—head—brain cancer	0.000285	0.0098	CbGeAlD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000278	0.00587	CbGpPWpGaD
Ketobemidone—PTGS1—endocrine gland—brain cancer	0.000261	0.00897	CbGeAlD
Ketobemidone—CYP2B6—central nervous system—brain cancer	0.00026	0.00894	CbGeAlD
Ketobemidone—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000259	0.00547	CbGpPWpGaD
Ketobemidone—PTGS1—head—brain cancer	0.000257	0.00886	CbGeAlD
Ketobemidone—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000256	0.00541	CbGpPWpGaD
Ketobemidone—PTGS1—central nervous system—brain cancer	0.000235	0.00809	CbGeAlD
Ketobemidone—CYP2C8—brain—brain cancer	0.00023	0.00792	CbGeAlD
Ketobemidone—OPRD1—GPCR ligand binding—PTCH2—brain cancer	0.000219	0.00463	CbGpPWpGaD
Ketobemidone—CYP3A4—endocrine gland—brain cancer	0.000218	0.00749	CbGeAlD
Ketobemidone—OPRM1—TCR Signaling Pathway—VAV1—brain cancer	0.000215	0.00455	CbGpPWpGaD
Ketobemidone—OPRM1—IL4-mediated signaling events—IRS2—brain cancer	0.000208	0.00441	CbGpPWpGaD
Ketobemidone—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	0.000208	0.00439	CbGpPWpGaD
Ketobemidone—CYP2B6—brain—brain cancer	0.000206	0.0071	CbGeAlD
Ketobemidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000206	0.00436	CbGpPWpGaD
Ketobemidone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000203	0.0043	CbGpPWpGaD
Ketobemidone—CYP3A4—central nervous system—brain cancer	0.000196	0.00675	CbGeAlD
Ketobemidone—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000195	0.00413	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000193	0.00407	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—OR4C12—brain cancer	0.000192	0.00406	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—OR14C36—brain cancer	0.000192	0.00406	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—PTCH2—brain cancer	0.000192	0.00406	CbGpPWpGaD
Ketobemidone—PTGS1—brain—brain cancer	0.000186	0.00642	CbGeAlD
Ketobemidone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000175	0.0037	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—OR4C12—brain cancer	0.000175	0.00369	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—OR14C36—brain cancer	0.000175	0.00369	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—OR14C36—brain cancer	0.000169	0.00356	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—OR4C12—brain cancer	0.000169	0.00356	CbGpPWpGaD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000168	0.00356	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000167	0.00353	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000165	0.00349	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000163	0.00345	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—PTCH2—brain cancer	0.000162	0.00343	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000157	0.00332	CbGpPWpGaD
Ketobemidone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000155	0.00328	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—OR4C12—brain cancer	0.000153	0.00324	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—OR14C36—brain cancer	0.000153	0.00324	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000148	0.00312	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000146	0.00308	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—OR14C36—brain cancer	0.000142	0.00301	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—OR4C12—brain cancer	0.000142	0.00301	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—OR14C36—brain cancer	0.000129	0.00274	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—OR4C12—brain cancer	0.000129	0.00274	CbGpPWpGaD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000129	0.00272	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000121	0.00255	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—SHH—brain cancer	0.000113	0.00239	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PTCH2—brain cancer	0.000112	0.00238	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—PTCH1—brain cancer	0.000107	0.00226	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—SMO—brain cancer	0.000107	0.00226	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—RELA—brain cancer	0.000107	0.00226	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—OR4C12—brain cancer	0.000103	0.00218	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—OR14C36—brain cancer	0.000103	0.00218	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—SHH—brain cancer	9.9e-05	0.00209	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PTCH2—brain cancer	9.86e-05	0.00209	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.83e-05	0.00208	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ABR—brain cancer	9.72e-05	0.00206	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—SMO—brain cancer	9.39e-05	0.00198	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—PTCH1—brain cancer	9.39e-05	0.00198	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	9.06e-05	0.00192	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—OR4C12—brain cancer	9.04e-05	0.00191	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—OR14C36—brain cancer	9.04e-05	0.00191	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.87e-05	0.00188	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ABR—brain cancer	8.83e-05	0.00187	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.81e-05	0.00186	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DTX2—brain cancer	8.77e-05	0.00185	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.75e-05	0.00185	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ABR—brain cancer	8.52e-05	0.0018	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—SHH—brain cancer	8.37e-05	0.00177	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PTCH2—brain cancer	8.34e-05	0.00176	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—PTCH1—brain cancer	7.93e-05	0.00168	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—SMO—brain cancer	7.93e-05	0.00168	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ABR—brain cancer	7.74e-05	0.00164	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DTX2—brain cancer	7.69e-05	0.00163	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—OR4C12—brain cancer	7.64e-05	0.00162	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—OR14C36—brain cancer	7.64e-05	0.00162	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ABR—brain cancer	7.2e-05	0.00152	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.18e-05	0.00152	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTCH2—brain cancer	6.65e-05	0.00141	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ABR—brain cancer	6.54e-05	0.00138	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DTX2—brain cancer	6.5e-05	0.00137	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HES5—brain cancer	6.44e-05	0.00136	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.35e-05	0.00134	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STRADA—brain cancer	6.25e-05	0.00132	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	6.15e-05	0.0013	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTCH2—brain cancer	5.83e-05	0.00123	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—SHH—brain cancer	5.8e-05	0.00123	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.67e-05	0.0012	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HES5—brain cancer	5.64e-05	0.00119	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—TRPC6—brain cancer	5.59e-05	0.00118	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—SMO—brain cancer	5.49e-05	0.00116	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PTCH1—brain cancer	5.49e-05	0.00116	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STRADA—brain cancer	5.48e-05	0.00116	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	5.4e-05	0.00114	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP2C9—brain cancer	5.37e-05	0.00114	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ABR—brain cancer	5.21e-05	0.0011	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—SHH—brain cancer	5.08e-05	0.00107	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GLI2—brain cancer	5.04e-05	0.00106	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTCH2—brain cancer	4.92e-05	0.00104	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—TRPC6—brain cancer	4.9e-05	0.00104	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PTCH1—brain cancer	4.82e-05	0.00102	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—SMO—brain cancer	4.82e-05	0.00102	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HES5—brain cancer	4.77e-05	0.00101	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GLI1—brain cancer	4.74e-05	0.001	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.64e-05	0.000981	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STRADA—brain cancer	4.63e-05	0.000979	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—VAV1—brain cancer	4.61e-05	0.000975	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ABR—brain cancer	4.57e-05	0.000967	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—BSG—brain cancer	4.56e-05	0.000965	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	4.56e-05	0.000964	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SUFU—brain cancer	4.49e-05	0.000949	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GLI2—brain cancer	4.42e-05	0.000934	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP2C9—brain cancer	4.38e-05	0.000925	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GFAP—brain cancer	4.33e-05	0.000916	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—SHH—brain cancer	4.29e-05	0.000908	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—VAV1—brain cancer	4.19e-05	0.000885	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GLI1—brain cancer	4.15e-05	0.000878	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.14e-05	0.000876	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—TRPC6—brain cancer	4.14e-05	0.000876	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HEY1—brain cancer	4.11e-05	0.000868	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—SMO—brain cancer	4.07e-05	0.000861	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PTCH1—brain cancer	4.07e-05	0.000861	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—VAV1—brain cancer	4.04e-05	0.000855	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DLL1—brain cancer	4.03e-05	0.000851	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SUFU—brain cancer	3.94e-05	0.000832	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—IDH1—brain cancer	3.93e-05	0.00083	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ABR—brain cancer	3.86e-05	0.000817	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GFAP—brain cancer	3.8e-05	0.000803	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.78e-05	0.000799	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GLI2—brain cancer	3.73e-05	0.000789	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—BSG—brain cancer	3.72e-05	0.000787	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—VAV1—brain cancer	3.67e-05	0.000776	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HEY1—brain cancer	3.6e-05	0.000761	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DLL1—brain cancer	3.53e-05	0.000746	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GLI1—brain cancer	3.51e-05	0.000742	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SHH—brain cancer	3.42e-05	0.000724	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—VAV1—brain cancer	3.42e-05	0.000722	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP2C9—brain cancer	3.34e-05	0.000706	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SUFU—brain cancer	3.33e-05	0.000703	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TRPC6—brain cancer	3.3e-05	0.000698	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTCH1—brain cancer	3.25e-05	0.000686	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SMO—brain cancer	3.25e-05	0.000686	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GFAP—brain cancer	3.21e-05	0.000679	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—IDH1—brain cancer	3.2e-05	0.000677	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.2e-05	0.000676	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—VAV1—brain cancer	3.1e-05	0.000656	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ENO2—brain cancer	3.1e-05	0.000656	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HEY1—brain cancer	3.04e-05	0.000643	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SHH—brain cancer	3e-05	0.000635	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DLL1—brain cancer	2.98e-05	0.000631	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	2.93e-05	0.000619	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TRPC6—brain cancer	2.89e-05	0.000612	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTCH1—brain cancer	2.85e-05	0.000602	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SMO—brain cancer	2.85e-05	0.000602	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—BSG—brain cancer	2.84e-05	0.0006	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP2C9—brain cancer	2.83e-05	0.000598	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	2.66e-05	0.000562	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.61e-05	0.000551	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOTCH2—brain cancer	2.59e-05	0.000549	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	2.57e-05	0.000543	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SHH—brain cancer	2.54e-05	0.000536	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ENO2—brain cancer	2.53e-05	0.000535	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2C9—brain cancer	2.52e-05	0.000533	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VAV1—brain cancer	2.47e-05	0.000523	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TRPC6—brain cancer	2.45e-05	0.000517	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—IDH1—brain cancer	2.44e-05	0.000516	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SMO—brain cancer	2.41e-05	0.000509	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTCH1—brain cancer	2.41e-05	0.000509	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—BSG—brain cancer	2.4e-05	0.000508	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	2.33e-05	0.000493	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOTCH2—brain cancer	2.27e-05	0.000481	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	2.17e-05	0.000459	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VAV1—brain cancer	2.17e-05	0.000459	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—BSG—brain cancer	2.15e-05	0.000454	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HES1—brain cancer	2.13e-05	0.00045	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—IDH1—brain cancer	2.07e-05	0.000437	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—IL2—brain cancer	2.06e-05	0.000436	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PDGFRA—brain cancer	2.03e-05	0.000428	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	1.97e-05	0.000417	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SPP1—brain cancer	1.97e-05	0.000416	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—BSG—brain cancer	1.96e-05	0.000414	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ENO2—brain cancer	1.93e-05	0.000408	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH2—brain cancer	1.92e-05	0.000407	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL2—brain cancer	1.87e-05	0.000396	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HES1—brain cancer	1.87e-05	0.000394	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—IDH1—brain cancer	1.84e-05	0.00039	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VAV1—brain cancer	1.83e-05	0.000388	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—IL2—brain cancer	1.81e-05	0.000382	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IRS2—brain cancer	1.78e-05	0.000376	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PDGFRA—brain cancer	1.78e-05	0.000376	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SPP1—brain cancer	1.72e-05	0.000365	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.68e-05	0.000356	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—IDH1—brain cancer	1.68e-05	0.000356	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL2—brain cancer	1.64e-05	0.000347	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ENO2—brain cancer	1.63e-05	0.000345	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HES1—brain cancer	1.58e-05	0.000333	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APC—brain cancer	1.57e-05	0.000332	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CG—brain cancer	1.57e-05	0.000332	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IRS2—brain cancer	1.56e-05	0.00033	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2—brain cancer	1.53e-05	0.000323	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.52e-05	0.000321	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.5e-05	0.000318	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PDGFRA—brain cancer	1.5e-05	0.000317	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ENO2—brain cancer	1.46e-05	0.000308	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SPP1—brain cancer	1.46e-05	0.000308	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—brain cancer	1.43e-05	0.000303	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CG—brain cancer	1.42e-05	0.000301	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—brain cancer	1.39e-05	0.000293	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APC—brain cancer	1.38e-05	0.000291	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CG—brain cancer	1.38e-05	0.000291	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.37e-05	0.00029	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ENO2—brain cancer	1.33e-05	0.000281	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IRS2—brain cancer	1.32e-05	0.000279	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BSG—brain cancer	1.29e-05	0.000273	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—brain cancer	1.25e-05	0.000265	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RELA—brain cancer	1.23e-05	0.000259	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB2—brain cancer	1.22e-05	0.000258	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APC—brain cancer	1.16e-05	0.000246	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CG—brain cancer	1.16e-05	0.000246	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CG—brain cancer	1.16e-05	0.000245	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—IDH1—brain cancer	1.11e-05	0.000235	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—brain cancer	1.11e-05	0.000234	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—brain cancer	1.08e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RELA—brain cancer	1.08e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB2—brain cancer	1.07e-05	0.000226	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CTNNB1—brain cancer	1.07e-05	0.000226	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—brain cancer	1.06e-05	0.000224	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—brain cancer	9.69e-06	0.000205	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—brain cancer	9.45e-06	0.0002	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—brain cancer	9.39e-06	0.000199	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CTNNB1—brain cancer	9.36e-06	0.000198	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—brain cancer	9.3e-06	0.000197	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RELA—brain cancer	9.09e-06	0.000192	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB2—brain cancer	9.04e-06	0.000191	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CG—brain cancer	8.85e-06	0.000187	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ENO2—brain cancer	8.77e-06	0.000185	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—brain cancer	8.64e-06	0.000183	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—brain cancer	8.45e-06	0.000179	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—brain cancer	8.24e-06	0.000174	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—brain cancer	8.19e-06	0.000173	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—brain cancer	8.15e-06	0.000172	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—brain cancer	7.98e-06	0.000169	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNB1—brain cancer	7.91e-06	0.000167	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—brain cancer	7.58e-06	0.00016	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CG—brain cancer	7.49e-06	0.000158	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—brain cancer	7.41e-06	0.000157	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—brain cancer	7.1e-06	0.00015	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—brain cancer	6.96e-06	0.000147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—brain cancer	6.89e-06	0.000146	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CG—brain cancer	6.69e-06	0.000141	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—brain cancer	6.4e-06	0.000135	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—brain cancer	6.26e-06	0.000132	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—brain cancer	6.22e-06	0.000132	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CG—brain cancer	6.1e-06	0.000129	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—brain cancer	5.26e-06	0.000111	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CG—brain cancer	4.02e-06	8.51e-05	CbGpPWpGaD
